MOG

MOG Molekülinformation

Englischer Name	Myelin-oligodendrocyte glycoprotein	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1	Target-Alias	NRCLP7，Myelin-oligodendrocyte glycoprotein，MOG，Myelin Oligodendrocyte Glycoprotein，MOG Ig-AluB，MOG Alpha-5，MOG AluA，MOG AluB，BTNL11，MOGIG2，BTN6
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

Englischer Name	Myelin-oligodendrocyte glycoprotein
Target-Alias	NRCLP7，Myelin-oligodendrocyte glycoprotein，MOG，Myelin Oligodendrocyte Glycoprotein，MOG Ig-AluB，MOG Alpha-5，MOG AluA，MOG AluB，BTNL11，MOGIG2，BTN6
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

MOG Produktliste

Attribut
Protein (3)
Produktbibliothek
Online (3)
Spezies
Human (2)Mouse (1)
Etikett
His Tag (1)His Tag & Avi Tag (2)
Marker
Unconjugated (1)Biotin-labeled (2)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Vorbestellen/Bestellen
HOT MOG-H82E5	Human	HEK293	Biotinylated Human MOG Protein, His,Avitag™ (MALS verified)	In den Warenkorb legen
MOG-H52H3	Human	HEK293	Human MOG Protein, His Tag, low endotoxin	In den Warenkorb legen
MOG-M82E7	Mouse	HEK293	Biotinylated Mouse MOG Protein, His,Avitag™ (MALS verified)	In den Warenkorb legen

Gesamtmenge3

MOG Molekülhintergrund

Myelin oligodendrocyte glycoprotein (MOG), is a single-pass transmembrane glycoprotein of the immunoglobulin (Ig) superfamily. MOG is a myelin protein exclusively expressed in the CNS at the outermost surface of myelin sheaths and oligodendrocyte membranes. This makes MOG a potential target of cellular and humoral immune responses in inflammatory demyelinating diseases. Due to its late postnatal developmental expression, MOG is an important marker for oligodendrocyte maturation.